🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Shoko Kure

Dana-Farber Cancer Institute

ORCID: 0000-0002-9536-9438
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “MUC1-C dependency in drug resistant HR+/HER2− breast cancer identifies a new target for antibody-drug conjugate treatment”.

MUC1-C dependency in drug resistant HR+/HER2− breast cancer identifies a new target for antibody-drug conjugate treatment

npj Breast Cancer(2025)10.1038/s41523-025-00751-w
N/A
0.292DataRank · unranked
6 citations

Atrayee Bhattacharya, Hiroki Ozawa, Naoki Haratake, Keisuke Shigeta, Atsushi Fushimi +16 more

Data from A Cohort Study of Cyclin D1 Expression and Prognosis in 602 Colon Cancer Cases

(2023)10.1158/1078-0432.c.6517933
N/A
0DataRank · unranked
0 citations

Katsuhiko Nosho, Natsumi Irahara, Shoko Kure, Kaori Shima, Yoshifumi Baba +6 more

Data from A Cohort Study of Cyclin D1 Expression and Prognosis in 602 Colon Cancer Cases

(2023)10.1158/1078-0432.c.6517933.v1
N/A
0DataRank · unranked
0 citations

Katsuhiko Nosho, Natsumi Irahara, Shoko Kure, Kaori Shima, Yoshifumi Baba +6 more

Data from DNMT3B Expression Might Contribute to CpG Island Methylator Phenotype in Colorectal Cancer

(2023)10.1158/1078-0432.c.6517612
N/A
0DataRank · unranked
0 citations

Kaori Shima, Natsumi Irahara, Shoko Kure, Yoshifumi Baba, Gregory J. Kirkner +9 more